|
The Remuneration Committee ("the Committee")
Remuneration paid to executive directors is considered and determined
by the Remuneration Committee. The Committee comprises Jonathan
Fry, the Chairman of the Committee, Michael Hartnall, Edward Wilson
and Richard McNeel, all of whom are non-executive directors. The
Chief Executive attends some meetings of the Committee in an advisory
capacity but is not a Committee member and is not present for discussions
which directly concern him.
Advisers to the Remuneration Committee
The Director of Human Resources is the internal adviser to the Committee
who provides information and advice to facilitate discussion and
decision-making on remuneration matters. He also provides the Company
and its subsidiaries with services which include the setting of
employment policies, recruitment of senior managers and overall
responsibility for all major human resources. The Director of Human
Resources was appointed by the Company.
New Bridge Street Consultants, who were appointed by the Committee,
provide information and data to the Committee to assist with the
development of executive remuneration and, in particular, in relation
to the development of share incentive schemes. They also help the
Committee agree appropriate packages reflecting the remuneration
policy.
The Committee also uses information provided by Hay Group, who
were appointed by the Company, relating to rates of pay for similar
positions in comparable companies.
Policy on directors' remuneration
Remuneration policy centres, and will continue to centre, on ensuring
that remuneration packages are sufficiently competitive, in both
fixed and variable terms, to attract, retain and motivate the right
calibre of executive director for each individual function. The
fixed and variable elements are of equal importance in achieving
these objectives. Incentive payments are conditional upon demanding
performance criteria so as to align incentive awards paid to directors
directly with the interests of shareholders. The constituent parts
of those packages are set out in the following paragraphs.
The policy of the Committee is to set basic salaries at a level
which is competitive with that of comparable businesses, with a
substantial proportion of the overall remuneration package being
linked to performance through participation in short-term and long-term
incentive schemes.
Salaries, fees and benefits
Salaries for executive directors are determined by the Committee
and are reviewed annually by it, taking into account individual
performance over the previous twelve months and pay and employment
conditions elsewhere in the Group. Any increases in basic salary
are effective from 1 July in each year.
Benefits relate to the provision of cars, life assurance and medical
cover.
Fees for non-executive directors are determined by the Board, having
regard to fees paid to non-executive directors in other UK quoted
companies. Individuals cannot vote on their own remuneration.
Short-term incentive arrangements
The 2002 annual bonus scheme for executive directors was based on
a shareholder value measure which takes into account not only post
tax earnings but also the cost of capital employed. Under this scheme,
directors could earn a bonus of up to 60 per cent of their basic
annual salaries based on a pre-determined scale. For 2002, executive
directors are entitled to a bonus under this scheme as shown in
the Directors' remuneration table. The
Company is proposing to introduce a revised annual bonus scheme.
For 2003, the performance measures used to determine the level of
annual reward will relate to operating profit and working capital
relative to the operating plan for that year. The maximum value
of an annual bonus under the scheme will be 70 per cent of basic
salary. Executive directors would be eligible to receive 80 per
cent (equivalent to 56.0 per cent of annual basic salary) of any
bonus in cash and 20 per cent (equivalent to 14.0 per cent of annual
basic salary) in the form of a deferred share award. The shares
would be held in trust by the Trustee of the Company's Employee
Share Ownership Trust for three years and would normally be forfeited
if an executive left or was dismissed.
Performance incentive
plan
The executive directors have previously participated in the Performance
Share Plan which is a long-term incentive plan. Total shareholder
return (TSR) was used as the performance measure in order to align
the level of reward to directors with the interests of shareholders.
Under the Performance Share Plan, participants are, on payment
of a nominal option price of 1 penny per share, able to exercise
options over shares in the Company in respect of an individual grant
if the performance criteria are met over a three year performance
period. Details of options granted to executive directors under
the Performance Share Plan are shown in the table
of directors' share options at the end of this report; this
includes details of options granted in 2000 which have now lapsed.
At the date of this report, grants made in 2001 and 2002 remain
outstanding. The maximum value of shares over which options were
granted in each of these two years was equivalent to 80 per cent
of annual basic salary as determined at 1 January in each year or
at date of appointment, if later.
The method used to assess whether the performance condition was
achieved is carried out by taking the TSR for each comparator company
over a three year period commencing 1 January in the year of the
relevant grant, with each company then placed in descending order
according to their TSR returns on the basis that the company with
the highest return is shown first. If the Company's TSR over the
same period is more than the company in the 30th percentile position,
all options will become exercisable; options to the value of 60
per cent of salary will be exercisable if in the top 40; 40 per
cent if in the top 50 and 20 per cent if in the top 60. No options
will be exercisable if the Company's performance is below the 60th
percentile position. The TSR information and calculations are carried
out by Alithos Limited.
The comparator companies for purposes of grants in 2001 were the
FTSE 250 companies, excluding investment trusts. With effect from
1 January 2002, the comparator companies were changed to a number
of national and international chemical companies which the Committee
considered to be a more appropriate group against which to measure
the performance of the Company. The current comparator companies
are:
| FTSE All Share Chemicals Sector |
The BOC Group Plc
Croda International Plc
Imperial Chemical Industries Plc
Porvair Plc
Yule Catto & Co Plc |
| FTSE Eurotop 300 Chemicals Sector |
Akzo Nobel NV
Ciba Specialty Chemicals Holdings Inc
DSM NV
Degussa AG |
| S&P 500 Chemicals Sector |
Dow Chemical Company
Rohm & Haas Company |
| Switzerland: Specialty Chemicals |
Lonza Group AG |
| S&P 400 Specialty Chemicals |
Ferro Corp
HB Fuller Co
Minerals Technologies Inc
Arch Chemicals Inc
Quaker Chemical Corp |
| France: Chemicals |
Rhodia SA |
In relation to awards made after 1 January 2002 under the Performance
Share Plan, the definition of market value in relation to a share
on any date was changed from the average of the daily middle market
quotations of such shares over a period of 12 months ending on the
dealing day immediately preceding such date to a period of 3 months.
In order to emphasise the long-term nature of the Performance Share
Plan, participants may only sell enough shares to cover their liability
for income tax arising on the exercise of an option within the two
year period following the date of the exercise of that option.
The Company's Employee Share Ownership Trust (ESOT) was established
in 1995 and has purchased some of the shares in the Company which
would be required if participants were entitled to exercise the
maximum number of options outstanding under the Performance Share
Plan. At 31 December 2002, the ESOT held 670,729 shares with a market
value of £0.19 million. The right to dividends on ordinary shares
owned by the ESOT has been waived.
Executive share option schemes
The 1987 Executive Share Option Scheme (the "1987 Scheme")
and the 1998 approved and unapproved Executive Share Option Schemes
(the "1998 Scheme") which replaced the 1987 Scheme, are
discretionary option schemes under which senior management below
Board level were granted options to purchase shares in the Company.
The option price at which options may be exercised is the average
market price over the five working days preceding the grant and
there is no discount. Options are capable of exercise after three
years and within ten years of the date of grant; those granted since
1995 are subject to earnings per share performance targets.
Proposed Executive Share Option Scheme
Following a review of the 1998 Scheme and the Performance Share
Plan, the Committee has concluded that shareholders' approval should
be sought at the 2003 AGM for the adoption of a new executive share
option scheme. The proposed scheme will replace the 1998 Scheme
and is designed to reflect changes to guidelines issued by institutional
investors and developments in market practice. After the adoption
of this scheme, no further awards will be made under the 1998 Scheme
or the Performance Share Plan. Existing awards will, however, continue
to be exercisable.
The Committee has concluded that an executive share option scheme
delivering market value share options is the most appropriate way
of aligning the interests of executives and shareholders. Participants,
who will include executive directors, will only benefit if and to
the extent that the share price increases above the option exercise
price. The exercise of the options will be subject to demanding
performance targets.
The key points of the proposed Scheme are as follows:
- options will be granted with an exercise price per share based
on the Company's share price immediately before the date of grant;
- the shares valued at the date of grant under options granted
to an executive in any financial year will not normally exceed
1.5 times basic salary;
- it is proposed that the exercise of options granted in 2003
to executive directors and other members of the management team
will be based partly on the Company's earnings per share growth
relative to inflation, and partly on the Company's total shareholder
return relative to the initial comparator group comprising national
and international chemical companies currently used in the Performance
Share Plan. The following targets will apply to executive directors
and other members of the management team.

Proportion of option grant
exercisable as multiplier
of base salary |
EPS/TSR split |

Performance criteria
to be met for options
to be exercisable |
| 0.0 to 0.7 |
50% EPS
50% TSR
|
Annual average EPS
growth
of 4% + RPI
TSR at median |
| 0.71 to 1.5 |
50% EPS
50% TSR |
Annual average EPS
growth
of 4.1% + RPI to 10% + RPI
(straight line vesting)
Median to upper quartile
(straight line vesting) |
The EPS performance condition and TSR condition will apply separately
to options granted under the proposed scheme.
- The performance conditions will initially be tested after three
years. If they are not satisfied then they may be retested after
four years, from the same fixed base point. To the extent they
are not met after the end of the fourth financial year, the options
will lapse.
- The Committee believes that this combination of targets is the
most appropriate way of measuring both the total returns to shareholders
relative to similar businesses and the Company's underlying financial
performance. The assessment of the performance targets will be
carried out by New Bridge Street Consultants who were chosen because
they are advisors to the Committee.
- Shareholding guidelines will be introduced for executive directors,
who will be expected to retain in shares 50 per cent of the post-tax
gains made from the exercise of options under the proposed scheme,
or the vesting of awards under the Performance Share Plan, or
annual bonuses paid in the form of shares, until they have built
up a shareholding equal to their basic salaries.
Savings related share option scheme
The 1998 UK savings related share option scheme (the "SAYE
Scheme") is a scheme under which all eligible UK employees,
including executive directors, can enter into savings contracts
with a building society or bank for a period of three or five years
and use the proceeds from their savings accounts to acquire shares
in the Company on the exercise of their options. The option price
at which options may be exercised is the average market price over
the five working days preceding the invitation date discounted by
a maximum of 20 per cent.
Options granted to executive directors under the SAYE Scheme are
not subject to performance conditions. The SAYE Scheme is an Inland
Revenue approved all-employee scheme, the terms of approval for
which do not allow the imposition of performance conditions on the
exercise of options.
Total Shareholder Return Performance
The following graph illustrates the Company's total shareholder
return since 1 January relative to the FTSE All Share Index, in
accordance with paragraph 4 of the Director's Remuneration Report
Regulations 2002.
The Company is a member of the FTSE All Share Index and accordingly
this is considered to be the most appropriate broad equity market
index for the purpose of measuring the Company's relative performance.
Source: Datastream

This graph looks at the value, by the end of 2002, of £100 invested
in Elementis on 31 December 1997 compared with that of £100 invested
in the FTSE All Share Index.
|